Lambongan, Rhys Harleigh P.
HRN: 20-97-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2023
CEFUROXIME 750MG (VIAL)
03/05/2023
03/11/2023
IV
265mg
Q8hrs
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes